RESTYLANE® 1ML

Where can I buy this product?

RESTYLANE® 1ml (without Lidocaine) is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support.

Product Information

What is RESTYLANE® 1ml (without Lidocaine)?

RESTYLANE® 1ml is a sterile, transparent gel of stabilized hyaluronic acid (HA) of non-animal origin, manufactured by Galderma. It utilizes the original and well-established NASHA® (Non-Animal Stabilized Hyaluronic Acid) technology. This technology creates a firmer HA gel with specific particle sizes, providing effective lift and volume. **This specific formulation does not contain lidocaine.**

It contains 20mg/mL of stabilized hyaluronic acid and is indicated for mid-to-deep dermis injection for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and for injection into the lips for lip augmentation in patients over the age of 21.

Storage: RESTYLANE® 1ml should be stored up to 25°C (77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all RESTYLANE® products are authentic, sourced through appropriate US channels, and handled according to manufacturer specifications.

How does RESTYLANE® 1ml (without Lidocaine) work?

RESTYLANE® 1ml leverages the NASHA® technology to provide a moderately firm HA gel that effectively adds volume upon injection. When placed in the mid-to-deep dermis, it physically lifts and fills moderate to severe wrinkles and folds, such as nasolabial folds and marionette lines, providing visible correction.

In the lips, its properties allow for noticeable volume enhancement and shaping. The NASHA® technology provides good structure and lift, making it a versatile option for various treatment goals. The HA component also contributes to tissue hydration.

Treatment results are visible immediately. The duration of effect for RESTYLANE® 1ml typically lasts around 6 to 9 months for wrinkles and folds, and up to 6 months for lips, although individual results vary. As this formulation does not contain lidocaine, appropriate anesthesia (e.g., topical, nerve block) is necessary for patient comfort.

Indications for Use

RESTYLANE® 1ml is indicated for patients over the age of 21 for:

• Correction of moderate to severe facial wrinkles and folds (e.g., nasolabial folds).
• Lip augmentation.

Appropriate patient selection, injection technique, and consideration of contraindications outlined in the US Prescribing Information (or IFU) are essential.

Primary Benefits

• Versatile filler suitable for moderate wrinkles/folds and lip augmentation (FDA-approved indications).
• Utilizes established NASHA® technology for effective lift and structure.
• Provides immediate, visible correction and volume enhancement.
• Long history of clinical use and established safety profile.
• **Lidocaine-free formulation** for sensitive patients or practitioner preference.

Side Effects and Safety Information

Common side effects observed in US clinical trials are typically mild to moderate, temporary, and related to the injection site, including:

• Swelling
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Lumps/Bumps (usually temporary)

Severe Adverse Events:
As with any dermal filler injection, there are risks of more serious complications. Practitioners must possess thorough anatomical knowledge and be prepared to manage complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. Prompt recognition and management according to established protocols are crucial.
• Severe allergic reactions (anaphylaxis) to HA
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals

Any signs of vascular compromise, infection, or persistent adverse reactions require immediate medical evaluation.